Primary leptomeningeal lymphoma: Report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature

Neurology

Volumn 41, Issue 1, 1991, Pages 95-100

  Lachance, D H ^a   O'Neill B P ^a   Macdonald, D R ^b   Jaeckle, K A ^c   Witzig, T E ^a   Li, C Y ^a   Posner, J B ^d  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; VINCRISTINE;

ADULT; AGED; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; LYMPHOMA; MALE; PRIORITY JOURNAL;

ADULT; AGED; ARACHNOID; CASE REPORT; CEREBROSPINAL FLUID; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; MENINGEAL NEOPLASMS; MIDDLE AGE; PIA MATER;

EID: 0025968251     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.41.1.95     Document Type: Article

References (39)

1. Li C-Y, Witzig TE, Phyliky RL, Ziesmer SC, Yam LT. Diagnosis of B-cell non-Hodgkin’s lymphoma of the central nervous system by immunocytochemical analysis of cerebrospinal fluid lymphocytes. Cancer 1986;57:737-744.
2. The Non-Hodgkin’s Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-2135.
3. Onofrio BM, Kernohan JW, Uihlein A. Primary meningeal sarcomatosis: a review of the literature and report of 12 cases. Cancer 1962;15:1197-1208.
4. Schaumburg HH, Plank CR, Adams RD. The reticulum cell sarcoma-microglioma group of brain tumors: a consideration of their clinical features and therapy. Brain 1972;95:199-212.
5. Houthoff HJ, Poppema S, Ebels EJ, Elema JD. Intracranial malignant lymphomas: a morphologic and immunocytologic study of 20 cases. Acta Neuropathol (Beri) 1978;44:203-210.
6. Letendre L, Banks PM, Reese DF, Miller RH, Scanlon PW, Kiely JM. Primary lymphoma of the central nervous system. Cancer 1982;49:939-943.
7. Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988;68:835-853.
8. Borit A, Altrocchi PH. Recurrent polyneuropathy and neurolymphomatosis. Arch Neurol 1971;24:40-49.
9. Gardiner J, de Graaf AS, Hewlett RH. Diagnostic problems of leptomeningeal lymphoma: a report of 3 cases. S Afr Med J 1987;71:457-459.
10. Griffin JW, Thompson RW, Mitchinson MJ, de Kiewiet JC, Welland FH. Lymphomatous leptomeningitis. Am J Med 1971;51:200-208.
11. Jazy FK, Shehata WM, Tew JM, Meyer RL, Boss HH. Primary intracranial lymphoma of the dura. Arch Neurol 1980;37:528-529.
12. Jones GR, Mason WH, Fischman LS, DeClerck TA. Primary central nervous system lymphoma without intracranial mass in a child: diagnosis by documentation of monoclonality. Cancer 1985;56:2804-2808.
13. Marsh WL Jr, Stevenson DR, Long HJ III. Primary leptomeningeal presentation of T-cell lymphoma: report of a patient and review of the literature. Cancer 1983;51:1125-1131.
14. Nguyen D, Nathwani BN. Primary meningeal small lymphocytic lymphoma. Am J Surg Pathol 1989;13:67-70.
15. Schmitt-Gräff A, Pfitzer P. Cytology of the cerebrospinal fluid in primary malignant lymphomas of the central nervous system. Acta Cytol 1983;27:267-272.
16. Kepes JJ, Maxwell JA, Hedeman L, Slaven J. Primary diffuse malignant lymphoma of the leptomeninges presenting as “pseudotumor cerebri.” Neurochirurgia (Stuttg) 1971;14:188-196.
17. Whisnant JP, Siekert RG, Sayre GP. Neurologic manifestations of the lymphomas. Med Clin North Am 1956 July;40:1151-1161.
18. O’Neill B, Banks P, O’Fallon J, Earle J, Colgan J. Primary central nervous system non-Hodgkin’s lymphoma (PCNSL): A clinical, radiological and pathological study of 51 patients in the CT-era (1974-1986) [Abstract], Proc Am Soc Clin Oncol 1987;6:70.
19. Helle TL, Britt RH, Colby TV. Primary lymphoma of the central nervous system: clinicopathological study of experience at Stanford. J Neurosurg 1984;60:94-103.
20. Hobson DE, Anderson BA, Carr I, West M. Primary lymphoma of the central nervous system: Manitoba experience and literature review. Can J Neurol Sci 1986;13:55-61.
21. Jellinger K, Radaskiewicz T, Slowik K. Primary malignant lymphoma of the central nervous system in man. Acta Neuropathol (Beri) 1975;suppl 6:95-102.
22. Murray K, Kun L, Cox J. Primary malignant lymphoma of the central nervous system: results of treatment of 11 cases and review of the literature. J Neurosurg 1986;65:600-607.
23. Zimmerman HM. Malignant lymphomas of the nervous system. Acta Neuropathol (Beri) 1975;suppl 6:69-74.
24. O’Neill BP, Colgan JP, Earle JD. Primary central nervous system lymphoma: unusual but characteristic clinical presentations [Abstract]. Ann Neurol 1987;22:162-163.
25. Bunn PA Jr, Schein PS, Banks PM, DeVita VT Jr. Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited. Blood 1976;47:3-10.
26. Ersboll J, Schultz HB, Thomsen BLR, Keiding N, Nissen NI. Meningeal involvement in non-Hodgkin’s lymphoma: symptoms, incidence, risk factors and treatment. Scand J Haematol 1985;35:487-496.
27. Harousseau JL, Vallantin X, Tricot G, Gisselbrecht C, Jacquillat C. Les localisations neuro-méningées au cours des lymphomes non Hodgkiniens de l’adulte. Sem Hôp Paris 1983;59:221-225.
28. Herman TS, Hammond N, Jones SE, Butler JJ, Byrne GE Jr, McKelvey EM. Involvement of the central nervous system by non- Hodgkin’s lymphoma: The Southwest Oncology Group experiences. Cancer 1979;43:390-397.
29. Law IP, Dick FR, Blom J, Bergevin PR. Involvement of the central nervous system in non-Hodgkin’s lymphoma. Cancer 1975;36:225-231.
30. Levitt LJ, Dawson DM, Rosenthal DS, Moloney WC. CNS involvement in the non-Hodgkin’s lymphomas. Cancer 1980;45:545-552.
31. MacKintosh FR, Colby TV, Podolsky WJ, et al. Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer 1982;49:586-595.
32. Mead GM, Kennedy P, Smith JL, et al. Involvement of the central nervous system by non-Hodgkin’s lymphoma in adults. A review of 36 cases. Q J Med 1986;60:699-714.
33. Weizsaecker M, Koelmel HW. Meningeal involvement in leukemias and malignant lymphomas of adults: incidence, course of disease, and treatment for prevention. Acta Neurol Scand 1979;60:363-370.
34. Matsuda M, McMurria H, VanHale P, Miller CA. CSF findings in primary lymphoma of the CNS [Letter]. Arch Neurol 1981;38:397.
35. Jellinger K, Radaskiewicz T. Involvement of the central nervous system in malignant lymphomas. Virchows Arch [A] 1976;370:345-362.
36. Ezrin-Waters C, Klein M, Deck J, Lang A. Diagnostic importance of immunological markers in lymphoma involving the central nervous system. Ann Neurol 1984;16:668-672.
37. Gabbai AA, Hochberg FH, Linggood RM, Bashir R, Hotleman K. High-dose methotrexate for non-AIDS primary central nervous system lymphoma. J Neurosurg 1989;70:190-194.
38. Kawakami Y, Tabuchi K, Ohnishi R, Asari S, Nishimoto A. Primary central nervous system lymphoma. J Neurosurg 1985;62:522-527.
39. Stewart DJ, Russell N, Atack EA, Quarrington A, Stolbach L. Cyclophosphamide, doxorubicin, vincristine, and dexamethasone in primary lymphoma of the brain: a case report. Cancer Treat Rep 1983;67:287-291.